Amber L Southwell

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 2

Top Topics

Blood Brain Barrier

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Science translational medicine

University of Central Florida

California Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Central Florida Jan 1o 2017

United States

Assistant Professor :: Burnett School of Biomedical Sciences- Neuroscience

Education History

California Institute of Technology Oct 1o 2001 - May 31o 2009

United States

PHD :: Biology

Publications

Morgan E Rook, Amber L Southwell
Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (2) (2022)
Amber L Southwell, Holly B Kordasiewicz, Douglas R Langbehn, Niels H Skotte, Matthew P Parsons, Erika B Villanueva, Nicholas S Caron, Michael E Østergaard, Lisa M Anderson, Yuanyun Xie, Louisa Dal Cengio, Hailey Findlay-Black, Crystal N Doty, Bethany Fitsimmons, Eric E Swayze, Thazha P Prakash, Lynn A Raymond, C Frank Bennett, Michael R Hayden
Huntingtin suppression restores cognitive function in a mouse model of Huntington's disease. Science translational medicine 10 (461) (2019)